GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,304 | -62.2% | 6,801 | -41.6% | 0.00% | – |
| Q2 2023 | $14,041 | +130.1% | 11,644 | +140.4% | 0.00% | – |
| Q1 2023 | $6,102 | +19.7% | 4,843 | +106.2% | 0.00% | – |
| Q4 2022 | $5,097 | -98.9% | 2,349 | -94.0% | 0.00% | -100.0% |
| Q3 2022 | $466,000 | +1403.2% | 39,023 | +927.5% | 0.00% | – |
| Q2 2022 | $31,000 | -91.2% | 3,798 | -90.6% | 0.00% | -100.0% |
| Q1 2022 | $351,000 | -41.9% | 40,602 | -24.2% | 0.00% | 0.0% |
| Q4 2021 | $604,000 | -33.5% | 53,535 | -26.0% | 0.00% | -50.0% |
| Q3 2021 | $908,000 | +38.0% | 72,306 | -10.8% | 0.00% | +100.0% |
| Q2 2021 | $658,000 | -18.7% | 81,099 | -7.4% | 0.00% | 0.0% |
| Q1 2021 | $809,000 | -12.8% | 87,624 | -8.7% | 0.00% | -50.0% |
| Q4 2020 | $928,000 | -36.4% | 96,024 | -18.5% | 0.00% | -33.3% |
| Q3 2020 | $1,460,000 | +62.2% | 117,749 | +69.7% | 0.00% | +50.0% |
| Q2 2020 | $900,000 | +1775.0% | 69,400 | +1339.8% | 0.00% | – |
| Q1 2020 | $48,000 | -90.1% | 4,820 | -84.6% | 0.00% | -100.0% |
| Q4 2019 | $487,000 | – | 31,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |